John Matthews

John Matthews has a diverse work experience spanning several companies and roles. John is currently the Vice President of Clinical Operations at Vortex Biosciences, where they lead global clinical development efforts using microfluidic chip technology to capture and characterize Circulating Tumor Cells for oncology treatment and monitoring. Previously, John has held positions such as Managing Director at Akela Consultancy Ltd and Global Head of Clinical Operations at CRO, where they managed large pharma partnerships and successfully transitioned complicated trials. John has also worked as a Senior Clinical Consultant at Curium Pharma, Vice President of Global Client Solutions at Syneos Health Limited, Director of Clinical Operations at Shionogi Limited, and Senior Project Manager at PAREXEL and PRA International. John's expertise includes overseeing clinical trials, managing budgets, forecasting profitability, and adhering to timelines.

John Matthews completed their Bachelor of Science (BSc) degree in Biological Sciences at Essex University from 1986 to 1989. Following this, they pursued a Master of Science (MSc) in Forensic Science at King's College London from 1990 to 1991. Prior to their university education, John Matthews attended Latymer Upper School. The specific duration and degree obtained at Latymer Upper School are unknown.